Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: B.REVERE who wrote (4128)	7/9/1998 6:10:00 PM
From: Anthony Wong	Respond to of 9523

BR, no information on conference call, sorry. I wonder whether they'll be on Squawk Box. Vivus has a conference call, but I guess you won't be interested. <ggg>

To: B.REVERE who wrote (4128)	7/9/1998 6:23:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Some information about review & approval of Viagra in Canada: Pfizer Canada submitted VIAGRA for review and approval by Health Canada in November 1997, six weeks after the U.S. submission to the FDA. In contrast to the U.S., VIAGRA was not eligible for priority review because the condition it treats, erectile dysfunction, is not life-threatening. Health Canada has said its performance standard for such a review is 300 days from its formal acceptance after screening, which occurred in December 1997. So it''' be round about October, 1998. Message 5147864